Skip to main content
Stonvex
Loading…
Home
Activity
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search…
⌘K
Search…
⌘K
Log in
Get Started
← Back to rankings
AIM
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Loading latest news…
52w low +1.0%
A
AIM
AIM ImmunoTech Inc.
Stonvex
☁️ News word cloud
Top words across the last 50 articles for this ticker.
immunotech
ampligen
cancer
2024
announces
announced
segment
corner
pancreatic
treatment
nyse
next
american
study
results
today
offering
purchase
webcast
globe
StonvexStonvexStonvexStonvex